More news: Software
Agency / Source: Kenexa | IBM

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

JDRF and IBM Collaborate to Research Risk Factors for Type 1 Diabetes in Children - Global Data Analysis Is First Precision Medicine Effort to Identify T1D Risk and Onset - JDRF.org / IBM.com
JDRF and IBM Collaborate to Research Risk Factors for Type 1 Diabetes in Children

 

PRZOOM - /newswire/ - New York, NY, United States, 2017/08/18 - Global Data Analysis Is First Precision Medicine Effort to Identify T1D Risk and Onset - JDRF.org / IBM.com. NASDAQ: KNXA

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

IBM and JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced a new collaboration to develop and apply machine learning methods to analyze years of global T1D research data and identify factors leading to the onset of T1D in children.

T1D affects approximately 1.25 million Americans, and it currently does not have a cure. This research collaboration is expected to create an entry point for T1D in the field of precision medicine, by combining JDRF’s connections to research teams around the globe and its subject matter expertise in T1D research with the technical capability and computing power of IBM.

“At JDRF, we are absolutely committed to seeing a world without type 1 diabetes, and with this partnership, we’re adding some of the most advanced computing power in the world to our mission,” said Derek Rapp, JDRF President and CEO. “JDRF supports researchers all over the world, but never before have we been able to analyze their data comprehensively, in a way that can tell us why some children who are at risk get T1D and others do not. IBM’s analysis of the existing data could open the door to understanding the risk factors of T1D in a whole new way, and to one day finding a way to prevent T1D altogether.”

IBM scientists will look across at least three different data sets and apply machine learning algorithms to help find patterns and factors at play, with the goal of identifying ways that could delay or prevent T1D in children. In order to match variables and data formats and compare the differing data sets, the scientists plan to leverage previously collected data from global research projects. Data analysis will explore the inclusion of genetic, familial, autoantibody and other variables to create a foundational set of features that is common to all data sets. The models that will be produced will quantify the risk for T1D from the combined dataset using this foundational set of features. As a result, JDRF will be in a better position to identify top predictive risk factors for T1D, cluster patients based on top risk factors, and explore a number of data-driven models for predicting onset.

“Nearly 40,000 new cases of type 1 diabetes will be diagnosed in the U.S. this year. And each new patient creates new records and new data points that, if leveraged, could provide additional understanding of the disease,” says Jianying Hu, Senior Manager and Program Director, Center for Computational Health at IBM Research. “The deep expertise our team has in artificial intelligence applied to healthcare data makes us uniquely positioned to help JDRF unlock the insights hidden in this massive data set and advance the field of precision medicine towards the prevention and management of diabetes.”

Future phases of the collaboration may consist of furthering the analysis of big data toward the goal of better understanding causes of T1D. They may also consist of analyzing more complex datasets, such as microbiome and genomics or transcriptomics data. Finally, but no less importantly, the knowledge gained through these efforts could also help JDRF in its pursuit of a cure for people with T1D.

About JDRF
JDRF (jdrf.org) is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D.

About IBM RESEARCH
For more than seven decades, IBM Research (ibm.com/research) has defined the future of information technology with more than 3,000 researchers in 12 labs located across six continents. Scientists from IBM Research have produced six Nobel Laureates, 10 U.S. National Medals of Technology, five U.S. National Medals of Science, six Turing Awards, 19 inductees in the National Academy of Sciences and 20 inductees into the U.S. National Inventors Hall of Fame.

About TYPE 1 DIABETES
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and at present nothing you can do to get rid of it.

Contact: Kristy Evans - JDRF
P: 212-859-7877 - E: kevans[.]jdrf.org.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Software Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Kenexa | IBM

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
Software Warnings - IMPORTANT:
Always be aware/cautious about what you download on your computer/mobile! PURCHASE SOFTWARE related keywords / Banner Ads. Click HERE for details!
.

 
  Your Banner Ad showing on ALL
Software articles,
CATCH Visitors via Your Competitors Announcements!


JDRF and IBM Collaborate to Research Risk Factors for Type 1 Diabetes in Children

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
IBM Research | JDRF
Contact: Adrienne Sabilia - IBM.com 
914-945-1402 acsabili[.]us.ibm.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kenexa | IBM securities in any jurisdiction including any other companies listed or named in this release.

Software via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Kenexa | IBM / Company Profile


Read Software Most Recent Related Press Releases:

InterSystems Recognized as a Leader by Independent Research Firm in Translytical Data Platforms Evaluation
Aptean Expands Offerings in France through Acquisition of Mistral
Universal Robina Corporation Selects Blue Yonder to Digitally Transform Planning Capabilities
Splunk Extends Strategic Collaboration Agreement with AWS
Infor Positioned as a Leader in the Nucleus CPQ Technology Value Matrix 2022
Siemens Streamlines Medical Standards Compliance for Linux OS Based Systems
Augmentir Awarded Frost & Sullivan’s 2022 Global Customer Value Leadership Award in the Connected Worker Solutions Industry
MAP Selects Blue Yonder to Transform Planning Capabilities
Openbravo Announces its Acquisition by Leading French Group DL Software
Renault Group Selects KPIT as a Strategic Technology Partner for Next Generation Software-Defined Vehicle (SDV) Program

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  JobsWare.com

Visit LEDtronics, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2022 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today